Updates on Use of Genomic Testing in Patients with High-Risk, Clinically Localized Prostate Cancer - Episode 5

Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing

Stephen J. Freedland, MD, details which patient populations he orders genomic testing for, and how the tests can address clinical challenges in prostate cancer treatment.

EP. 1: Staging, Grading, and Risk Stratification of Prostate Cancer
EP. 2: Treatment Options for High-Risk, Clinically Localized Prostate Cancer
EP. 3: Clinical Challenges Surrounding Treatment Decision-Making in Clinically Localized Prostate Cancer
EP. 4: The Potential for Overtreatment or Undertreatment of Prostate Cancer
Now Viewing
EP. 5: Addressing Clinical Challenges of Prostate Cancer Management with the Use of Genomic Testing
EP. 6: Available Genomic Tests for Clinically Localized Prostate Cancer
EP. 7: Clinical Study Data in Prostate Cancer Genomic Testing
EP. 8: Clinical Implications of Using Genomic Testing Results in Prostate Cancer Risk-Stratification and Treatment Selection
EP. 9: Exciting Emerging Data in Prostate Cancer